CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

IDEAYA Biosciences Announces ESMO 2026 Presentations for Darovasertib and IDE849 Clinical Programs

ConferenceDarovasertibIDE849Neutral
AI Analysis

Summary

IDEAYA Biosciences announced it will present clinical data on darovasertib and IDE849 at the 2026 ESMO conference.

Importance:5/10
Sentiment:
0.00
ESMOconferenceclinical_datadarovasertibIDE849
Related Companies

Read the original article

Published by yahoo_finance on July 17, 2026 1:00 PM

Read Original